Juvena Therapeutics raised $30.49 million to develop protein-based therapeutics that restore cellular function and promote tissue repair for chronic and rare diseases.
Juvena Therapeutics raised $30.49 million to develop protein-based therapeutics that restore cellular function and promote tissue repair for chronic and rare diseases.